BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
nitric oxide metabolic process
,
Obesity
,
Lymphocyte
,
Neocentromeres
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CDK7
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Basophil of peripheral blood
Oral mucosa
Leukocyte (polymorphonuclear) of peripheral blood
T Lymphocyte (regulatory) of peripheral blood
Esophagus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Melanoma A375 cells treated with 45 different siRNA knockdowns
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.
Cyclin-dependent kinase 7 is essential for spermatogenesis by regulating retinoic acid signaling pat…
Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular …
Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition.
CDK7 in breast cancer: mechanisms of action and therapeutic potential.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ